Meningococcal Infections
📧 Sign up to get email alerts when something new happens for Meningococcal Infections.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-04-02Clinical Trial Update: Non-Inferiority of Meningococcal Vaccine GSK134612 Versus Mencevax™ in 11-17 Year-Old Subjects [Phase 3]
Phase 3 trial shows that the meningococcal vaccine GSK134612 is non-inferior to Mencevax in 11-17-year-olds.
-
CLINICAL_TRIALS trial_result · 2018-03-09Clinical Trial Update: N. Meningitidis Carriage Study
Neisseria meningitidis carriage study (NCT01808365) has completed. Sponsor: GlaxoSmithKline.
-
CLINICAL_TRIALS trial_result · 2018-01-08Clinical Trial Update: Safety of a Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine in Healthy Subjects in Vietnam [Phase 2]
Phase 2 clinical trial assessing the safety of a meningococcal polysaccharide diphtheria toxoid conjugate vaccine in healthy Vietnamese adul…
-
CLINICAL_TRIALS trial_result · 2017-12-15Clinical Trial Update: Safety & Immunogenicity Study of Meningococcal Vaccine GSK134612 Given With Priorix-Tetra™ to 12-23 Month-Old Children [Phase 3]
Phase 3 safety and immunogenicity study of the meningococcal vaccine GSK134612 given with Priorix-Tetra in 12-23 month-olds; trial completed…
-
CLINICAL_TRIALS trial_result · 2017-12-13Clinical Trial Update: Combined Study - Phase 3b MenB Long Term Persistence in Adolescents [Phase 3]
Phase 3b trial update on MenB long-term persistence in adolescents completed with results posted in 2017.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-10-19Clinical Trial Update: Comparison of GSK Biologicals' Meningococcal Vaccine (GSK134612) and Licensed MenC-CRM197 Vaccine in Healthy Children [Phase 3]
Phase 3 trial comparing GSK134612 meningococcal vaccine with a licensed MenC-CRM197 vaccine in healthy children has completed with results p…
-
CLINICAL_TRIALS trial_result · 2017-09-06Clinical Trial Update: Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Meningococcal Conjugate Vaccine (GSK134612) When Co-administered With Boostrix® in Subjects Between 11 and 25 Years of Age [Phase 3]
Phase 3 trial evaluating immunogenicity and safety of GSK134612 meningococcal conjugate vaccine co-administered with Boostrix in individuals…
-
CLINICAL_TRIALS trial_result · 2017-08-03Clinical Trial Update: Immune Response & Safety of GSK Biologicals' Mencevax™ ACWY in Subjects Primed in the DTPW-HBV=HIB-MENAC-TT-011 Study [Phase 3]
Phase 3 trial evaluating immune response and safety of GlaxoSmithKline's Mencevax ACWY meningococcal vaccine in subjects previously primed i…
-
CLINICAL_TRIALS trial_result · 2017-07-21Clinical Trial Update: Trial to Assess Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Meningococcal ABCWY Vaccine as Compared to Meningococcal B Vaccine in Adolescents [Phase 2]
Phase 2 trial evaluating immunogenicity and safety of GSK's Meningococcal ABCWY vaccine versus Meningococcal B vaccine in adolescents (compl…
-
CLINICAL_TRIALS trial_result · 2017-04-28Clinical Trial Update: Immunogenicity and Safety Study of GSK Biologicals' Meningococcal Vaccine Given as One Dose to Healthy Subjects Above 56 Years [Phase 3]
Phase 3 trial update on immunogenicity and safety of one-dose meningococcal vaccine in healthy adults over 56; results posted.
-
CLINICAL_TRIALS trial_result · 2016-11-15Clinical Trial Update: Regulation of Mucosal Immune Response to Systemic MenB Vaccine [Phase 2]
Phase 2 trial update evaluating regulation of mucosal immune response to a systemic meningococcal B vaccine; study completed.
-
CLINICAL_TRIALS trial_result · 2016-10-25Clinical Trial Update: Study in Adolescents/Adults to Evaluate the Persistence up to 3.5 Yrs of GSK Biologicals Meningococcal Vaccine 134612 [Phase 2]
A Phase 2 trial in adolescents and adults studied the long-term persistence (up to 3.5 years) of GSK Biologicals' meningococcal vaccine cand…
-
CLINICAL_TRIALS trial_result · 2016-10-07Clinical Trial Update: Study in Children to Evaluate the Immunogenicity and Safety of 4 Formulations of GSK Bio MenACWY-TT Conjugate Vaccine [Phase 2]
Phase 2 trial evaluating the immunogenicity and safety of four formulations of the GlaxoSmithKline MenACWY-TT meningococcal conjugate vaccin…
-
CLINICAL_TRIALS trial_result · 2016-09-21Clinical Trial Update: Evaluate 4 Different Formulations of Meningococcal Serogroups A, C, W-135, Y Conjugate Vaccine When Given as 1 Dose to Healthy Subjects Aged 15-19 Yrs [Phase 2]
A Phase 2 trial conducted by GlaxoSmithKline evaluated four formulations of a meningococcal ACWY conjugate vaccine given as a single dose to…
-
CLINICAL_TRIALS trial_result · 2016-09-21Clinical Trial Update: Assess the Non-inferiority of GSK Biologicals' Mencevax™ ACWY (Manufactured by a New Process) vs Mencevax™ ACWY (the Already Existing Vaccine in the Market) When Given as a Single Dose to Subjects Aged 2-30 Yrs [Phase 4]
A Phase 4 trial assessed whether GSK's Mencevax ACWY manufactured via a new process is non-inferior to the existing vaccine when given as a …
-
CLINICAL_TRIALS trial_result · 2015-04-23Clinical Trial Update: Immunogenicity and Safety of Group A, C, Y & W-135 Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine [Phase 2]
Phase 2 trial evaluating the immunogenicity and safety of a group A, C, Y & W-135 meningococcal polysaccharide diphtheria toxoid conjugate v…
-
CLINICAL_TRIALS trial_result · 2015-03-23Clinical Trial Update: Safety, Tolerability and Immunogenicity of Meningococcal B Recombinant Vaccine Administered With or Without Routine Infant Vaccinations to Healthy Infants According to Different Immunization Schedules [Phase 2]
Phase 2 trial evaluating the safety, tolerability, and immunogenicity of a Meningococcal B recombinant vaccine in healthy infants, given wit…
-
CLINICAL_TRIALS trial_result · 2014-09-19Clinical Trial Update: Persistence of Antibodies and Kinetics of B Cell Response in Healthy Children After Vaccination With MCC Vaccine [Phase 4]
A Phase 4 study reports on durability of antibody responses and B cell kinetics in healthy children after MCC meningococcal vaccination.
-
CLINICAL_TRIALS trial_result · 2013-05-28Clinical Trial Update: Study of a Single Dose of Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine (SP284) in Japanese Subjects [Phase 3]
Phase 3 trial evaluating a single-dose SP284 meningococcal polysaccharide diphtheria toxoid conjugate vaccine in Japanese subjects has compl…
-
CLINICAL_TRIALS trial_result · 2013-01-14Clinical Trial Update: Safety Study of Group A, C, Y & W-135 Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine for Meningitis [Phase 1]
Phase 1 safety study of a meningococcal polysaccharide diphtheria toxoid conjugate vaccine covering serogroups A, C, Y and W-135 has complet…
-
CLINICAL_TRIALS trial_result · 2012-07-20Clinical Trial Update: Immuno,Safety of GSK Vaccine 134612 Given at Age of 12-15 Months 15-18 Months Post-priming With GSK Vaccine 792014 [Phase 3]
Phase 3 trial update evaluating safety of GSK vaccine given at 12-15 months and 15-18 months post-priming with GSK vaccine 792014 for mening…
-
CLINICAL_TRIALS trial_result · 2012-05-22Clinical Trial Update: Lot Consistency, Immuno, Safety of Meningococcal Vaccine GSK134612 Given With Fluarix™ to 18-55 Year-Old Adults [Phase 3]
A Phase 3 trial assessing lot consistency, immunogenicity, and safety of the meningococcal vaccine GSK134612 given with Fluarix in adults ag…
-
CLINICAL_TRIALS trial_result · 2011-06-09Clinical Trial Update: Safety and Immune Response of Novartis of MenACWY Conjugate Vaccine When Given to Healthy Children [Phase 3]
Phase 3 trial results assessing the safety and immune response of the MenACWY conjugate vaccine in healthy children have been completed and …
-
CLINICAL_TRIALS trial_result · 2010-09-24Clinical Trial Update: A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In US Adolescents and Adults [Phase 3]
Phase 3 trial evaluating the safety and immune response of the Novartis Meningococcal ACWY conjugate vaccine (Menveo) in US adolescents and …
-
CLINICAL_TRIALS trial_result · 2010-08-04Clinical Trial Update: A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Healthy Adults [Phase 3]
Phase 3 trial update evaluating safety and immune response of the Novartis meningococcal ACWY vaccine in healthy adults. The study is comple…